Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00005896
What this trial is testing

Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia

Who this might be right for
Fanconi's Anemia
University of Minnesota 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Not applicableNot Yet RecruitingNCT07717164
What this trial is testing

PRAISE-IR Versus CIBMTR Controls

Who this might be right for
ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)
Miltenyi Biomedicine GmbH 51
Not applicableStudy completedNCT02144532
What this trial is testing

Wearing a Compression Garment for Patients With Hypermobility Type of Ehlers-Danlos Syndrome

Who this might be right for
Ehlers-Danlos Syndrome Hypermobility Type
Hospices Civils de Lyon 48
Testing effectiveness (Phase 2)UnknownNCT03292263
What this trial is testing

ASCT With Nivolumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
St. Petersburg State Pavlov Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00072514
What this trial is testing

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT01369849
What this trial is testing

Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 15
Not applicableWithdrawnNCT06581055
What this trial is testing

A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00346255
What this trial is testing

BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
ImmunoGen, Inc. 37
Not applicableStudy completedNCT04151615
What this trial is testing

VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boryung Pharmaceutical Co., Ltd 203
Not applicableStudy completedNCT03870633
What this trial is testing

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Who this might be right for
Chronic Lymphocytic LeukemiaPlasma Cell Myeloma
Alliance for Clinical Trials in Oncology 521
Testing effectiveness (Phase 2)Active Not RecruitingNCT00792948
What this trial is testing

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1+4 more
National Cancer Institute (NCI) 97
Large-scale testing (Phase 3)Study completedNCT01395199
What this trial is testing

Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

Who this might be right for
ThalassemiaIron Overload
University of Campinas, Brazil 62
Testing effectiveness (Phase 2)Study completedNCT01244763
What this trial is testing

Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

Who this might be right for
Chronic Kidney DiseaseAnemia
Kyntra Bio 145
Post-approval studies (Phase 4)Study completedNCT00115206
What this trial is testing

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Amgen
Not applicableUnknownNCT00336206
What this trial is testing

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Tawam Hospital 60
Not applicableStudy completedNCT02410252
What this trial is testing

Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin Lymphoma
Massachusetts General Hospital 25
Not applicableStudy completedNCT03389347
What this trial is testing

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Plasma Cell LeukemiaRecurrent Multiple MyelomaRefractory Multiple Myeloma
University of Washington 40
Post-approval studies (Phase 4)Study completedNCT05583838
What this trial is testing

Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Who this might be right for
Previously Treated Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 157
Post-approval studies (Phase 4)Looking for participantsNCT05935358
What this trial is testing

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

Who this might be right for
Severe Hemophilia A
Octapharma 28
Next Page